학술논문
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial
Document Type
Article
Author
Kater, A.P.; Arslan, Ö.; Demirkan, F.; Herishanu, Y.; Ferhanoglu, B.; Diaz, M.G.; Leber, B.; Montillo, M.; Panayiotidis, P.; Rossi, D.; Skarbnik, A.; Tempescul, A.; Turgut, M.; Mellink, C.H.; van der Kevie-Kersemaekers, A.-M.F.; Lanham, S.; Sale, B.; Del Rio, L.; Forconi, F.; Popovic, R.; Chyla, B.J.; Busman, T.; Komlosi, V.; Wang, X.; Sail, K.; Pena, G.E.; Vizkelety, T.
Source
In: The Lancet Oncology . (The Lancet Oncology, April 2024, 25(4):463-473)
Subject
Language
English
ISSN
14745488
14702045
14702045